antibodies
UK study raises hopes of long COVID test within months
Phil Taylor
antibodies, COVID-19, diagnostics, Long COVID
0 Comment
Partner content/ Press releases/ R&D
Quick Update – Under 2 Weeks Remaining – ADC Conference
Pavan Solanki
antibodies, Bristol-Myers Squibb, highly potent, Janssen, Pfizer
ADC Summit
Partner content/ Press releases/ R&D
BioPharmaLogic, Antikor Biopharma and UCL Host 2 Must Attend Workshops
Pavan Solanki
ADC payloads, ADCs, antibodies, conjugates, highly potent
0 Comment
ADC Summit
Partner content/ Press releases/ R&D
Exclusive Interview Released with HPAPI Project Services
Pavan Solanki
antibodies, api, highly potent, HPAPI, pharmaceutical ingredients
0 Comment
SMi’s 2nd Annual HPAPI 2018 Conference
Partner content/ Press releases/ R&D
BioPharmaLogic, Antikor Biopharma and UCL Host Two Workshops at the ADC conference
Pavan Solanki
antibodies, antikor, conjugates, science, workshop
0 Comment
SMi’s 6th annual ADC Conference
Partner content/ Press releases/ R&D
Exclusive Speaker Interview from Seattle Genetics for SMi’s ADC conference
Pavan Solanki
ADC payloads, antibodies, conjugates, HPAPI, Seattle Genetics
0 Comment
Interview from Seattle Genetics
Partner content/ Press releases/ R&D
Hear the Keynote Addresses from MedImmune and Spirogen this April
Pavan Solanki
ADC payloads, antibodies, dna, drug-conjugates, PK-PD
0 Comment
Antibodies & Antibody Drug Conjugates
Partner content/ Press releases/ R&D
Hear from Janssen and Antikor Biopharma at SMi’s ADC Conference, May 2018
Pavan Solanki
antibodies, antikor, conjugates, Janssen, PK-PD
0 Comment
Janssen and Antikor Biopharma Speak this April